Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Els O. Witteveen
Observed names:
E O Witteveen,
E Witteveen,
E. O. Witteveen,
E. WITTEVEEN,
E. Witteveen,
Els O Witteveen,
Els P O Witteveen,
Els Witteveen,
Witteveen, Els
show all 9
Institution:
University Medical Center Utrecht
Observed institutions:
Utrecht University,
Universitair Ziekenhuis Leuven,
Beatson West of Scotland Cancer Centre,
Slotervaartziekenhuis,
The Netherlands Cancer Institute,
University Medical Center Utrecht,
Eli Lilly (Netherlands),
Sunnybrook Hospital,
KU Leuven
show all 9
OpenAlex ID:
A5110169488
The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: A systematic review
2007
·
Flora Vernooij
, Peter Heintz
, et al.
·
Gynecologic Oncology
·
299
The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
2008
·
Jeanine Roodhart
, Marlies Langenberg
, et al.
·
Current Clinical Pharmacology
·
209
A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer Patients
2007
·
Isa E.L.M. Kuppens
, Els O. Witteveen
, et al.
·
Clinical Cancer Research
·
203
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
2021
·
I. Vergote
, A. González-Martín
, et al.
·
Annals of Oncology
·
173
PDF
Pharmacogenetic Screening of CYP3A and ABCB1 in Relation to Population Pharmacokinetics of Docetaxel
2006
·
Tessa M. Bosch
, Alwin D.R. Huitema
, et al.
·
Clinical Cancer Research
·
135
Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study
2010
·
Kristel Van Calsteren
, René Verbesselt
, et al.
·
Acta Obstetricia Et Gynecologica Scandinavica
·
132
PDF
Phase I Clinical Evaluation of Weekly Administration of the Novel Vascular-Targeting Agent, ZD6126, in Patients With Solid Tumors
2006
·
Laurens V. Beerepoot
, Sandra A. Radema
, et al.
·
Journal of Clinical Oncology
·
119
Association of Chemotherapy Timing in Pregnancy With Congenital Malformation
2021
·
Mathilde van Gerwen
, Charlotte Maggen
, et al.
·
JAMA Network Open
·
90
PDF
Late Release of Circulating Endothelial Cells and Endothelial Progenitor Cells after Chemotherapy Predicts Response and Survival in Cancer Patients
2010
·
Jeanine M. Roodhart
, Marlies H. Langenberg
, et al.
·
Neoplasia
·
83
PDF
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy
2020
·
Tineke Vandenbroucke
, Magali Verheecke
, et al.
·
European Journal of Cancer
·
73
PDF
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mullerian Adenosarcoma of the Female Genital Tract
2014
·
Michael Leonard Friedlander
, Alan Covens
, et al.
·
International Journal of Gynecological Cancer
·
67
Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study.
2003
·
Laurens V Beerepoot
, Els O Witteveen
, et al.
·
PubMed
·
64
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C β-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer
2007
·
Jeany M. Rademaker-Lakhai
, Laurens V. Beerepoot
, et al.
·
Clinical Cancer Research
·
56
Clinical and Pharmacologic Study of the Novel Prodrug Delimotecan (MEN 4901/T-0128) in Patients with Solid Tumors
2008
·
Stephan A. Veltkamp
, Els O. Witteveen
, et al.
·
Clinical Cancer Research
·
47
Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
1990
·
L F Verdonck
, E O Witteveen
, et al.
·
PubMed
·
33
Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer
2006
·
M. VERHAAR-LANGEREIS
, A. KARAKUS
, et al.
·
International Journal of Gynecological Cancer
·
31
European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Industry Partners—First Update 2015
2015
·
Andreas du Bois
, Alexander Reuss
, et al.
·
International Journal of Gynecological Cancer
·
27
Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer
2020
·
Rhode Bijlsma
, Roel Wouters
, et al.
·
ESMO Open
·
22
PDF
Targeting the Endothelin Axis with Atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma
2012
·
G Groenewegen
, M Walraven
, et al.
·
British Journal of Cancer
·
17
PDF
Long-term neurocognitive, psychosocial, and physical outcomes after prenatal exposure to radiotherapy: a multicentre cohort study of the International Network on Cancer, Infertility, and Pregnancy
2024
·
Indra A Van Assche
, Kristel Van Calsteren
, et al.
·
The Lancet Child & Adolescent Health
·
12
PDF
Phase I and pharmacokinetic evaluation of enzastaurin combined with gemcitabine and cisplatin in advanced cancer
2006
·
L. Beerepoot
, J. Rademaker-Lakhai
, et al.
·
Journal of Clinical Oncology
·
12
A phase I study of IMC-11F8, a fully human anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in patients with solid tumors. Interim results
2006
·
B. Kuenen
, E. Witteveen
, et al.
·
Journal of Clinical Oncology
·
9
Phase I and pharmacologic study of enzastaurin HCl, gemcitabine and cisplatin
2004
·
J. M. Rademaker-Lakhai
, L. Beereport
, et al.
·
Journal of Clinical Oncology
·
8
Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary care
2018
·
Charles W Helsper
, Liesbeth M Van Vliet
, et al.
·
British Journal of General Practice
·
6
PDF
Phase I and pharmacological study of oral topotecan and the BCRP and P-gp inhibitor elacridar
2004
·
J. H. Schellens
, I. E. Kuppens
, et al.
·
Journal of Clinical Oncology
·
4
Show more works
View as search
Works count:
33
Citation count:
1,931
H-index:
18
I10-index:
21
Year
Topic
Type